Home › Ovarian Epithelial Carcinoma › Louisiana
Ovarian Epithelial Carcinoma clinical trials in Louisiana
4 studies for Ovarian Epithelial Carcinoma are looking for participants at sites in Louisiana.
Cities in Louisiana
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- Women'S Cancer Care /ID# 276469, Covington
- University Medical Center New Orleans /ID# 274755, New Orleans
- Trials 365 /ID# 274310, Shreveport
RecruitingPhase 2
Ages 18 and older · Women · Updated Sep 29, 2026 · NCT06890338Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
- Louisiana State University HSC - NO Cancer Center, New Orleans
RecruitingPhase 3
Ages 18 and older · Women · Updated Sep 15, 2026 · NCT06915025ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Tulane Cancer Center, New Orleans
- Christus Highland/ Boniol, Shreveport
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT05059444Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- Trials365 LLC, Shreveport
RecruitingPhase 3
Ages 18 and older · Women · Updated Jul 2, 2026 · NCT06819007From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.